BIT 5.41% 3.9¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-107

  1. 11,796 Posts.
    lightbulb Created with Sketch. 5977
    100% agree ,,,

    Full Data Read Out Required .... Phase II Primary End Points Achieved ,,,, the opposite side of the coin ,, Phase II Failure would see a 1c stock at best..
    Company needs to gain further Editorial to push the news ,,, ASX Announcements are the bare minimum ASX Regulatory Requirement..

    Looking forward to greater market awareness in the future NZT
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.002(5.41%)
Mkt cap ! $35.18M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $22.54K 592.1K

Buyers (Bids)

No. Vol. Price($)
3 618000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 483271 5
View Market Depth
Last trade - 15.59pm 08/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.